Latest Mylan Stories
POTTERS BAR, England, and PITTSBURGH, March 3, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) (the "Parent") and Mylan Inc.
POTTERS BAR, England and PITTSBURGH, March 2, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Mylan Inc. today announced that Mylan Inc.
Provides 2015 Adjusted Diluted EPS Guidance Range of $4.00 to $4.30, Representing Year-Over-Year Growth of 17%, or 21% on a Constant Currency Basis POTTERS BAR, England and PITTSBURGH, March
POTTERS BAR, England and PITTSBURGH, Feb. 27, 2015 /PRNewswire/ -- Mylan N.V. and Mylan Inc.
PITTSBURGH and HYDERABAD, India, Feb. 23, 2015 /PRNewswire/ -- Mylan Inc.
Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 says the strong preference for generic drugs is the major market driver while and the strong focus on the high - potency API is the
Phase 3 registrational studies of TD-4208 are anticipated to begin in 2015 GEORGE TOWN, Grand Cayman and PITTSBURGH, Feb. 2, 2015 /PRNewswire/ -- Theravance Biopharma, Inc.
Expected to be immediately accretive to Mylan's adjusted diluted earnings per share upon closing PITTSBURGH and MUMBAI, India, Feb. 2, 2015 /PRNewswire/ -- Mylan Inc.
PITTSBURGH, Jan. 29, 2015 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced that at a Special Meeting of Shareholders held Jan.
- A woman chauffeur.
- A woman who operates an automobile.